3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow 10xBio, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity 10XB-101 Solution for Injection, 6.0%, Placebo Solution for Injection (no active ingredient) - Subcutaneous Fat Disorder | Phase 2 | Completed | 10xBio, LLC | 13 | 2023-05-04 | 2025-06-29 |
| A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat 10XB-101 Solution for Injection, 10XB-101 Vehicle Solution for Injection - Submental Fat | Phase 2 | Completed | 10xBio, LLC | 51 | 2021-10-19 | 2025-06-29 |
| A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin") 10XB-101 Solution for Injection - Submental Fat | Phase 2 | Completed | 10xBio, LLC | 15 | 2019-10-10 | 2024-04-10 |
Injections (3) · Polidocanol (1)
United States (3)
John Dobak, M.D. (1) · John Dobak, MD (1)